首页> 外文OA文献 >Eukaliuric diuresis and natriuresis in response to the KATP channel blocker U37883A: Micropuncture studies on the tubular site of action
【2h】

Eukaliuric diuresis and natriuresis in response to the KATP channel blocker U37883A: Micropuncture studies on the tubular site of action

机译:响应KATP通道阻滞剂U37883A的真尿利尿和利钠尿症:肾小管作用部位的微针研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Systemic application of U37883A, a blocker of ATP sensitive potassium (KATP) channels, elicits diuresis and natriuresis without significantly altering urinary potassium excretion.To elucidate tubular sites of action upstream to the distal nephron, micropuncture experiments were performed in nephrons with superficial glomeruli of anaesthetized Munich-Wistar-Frömter rats during systemic application of U37883A (1, 5 or 15 mg kg−1 i.v.).The observed eukaliuric diuresis and natriuresis in response to U37883A at 15 mg kg−1 was accompanied by an increase in early distal tubular flow rate (VED) from 10–18 nl min−1 reflecting a reduction in fractional reabsorption of fluid up to this site (FR-fluid) of 13%. The latter proposed an effect on water-permeable segments such as the proximal tubule which could fully account for the observed reduction in fractional reabsorption of Na+ up to the early distal tubule (FR-Na+) of 8% and the increase in early distal tubular Na+ concentration ([Na+]ED) from 35–51 mM whereas [K+]ED was left unaltered.In comparison, furosemide (3 mg kg−1 i.v.), which acts in the water-impermeable thick ascending limb, elicited diuresis, natriuresis and kaliuresis which were associated with a fall in FR-Na+ of 10% with no change in FR-fluid, and a rise in [Na+]ED from 42–117 mM and [K+]ED from 1.2–5.7 mM with no change in VED.Direct late proximal tubular fluid collections confirmed a significant inhibition of fluid reabsorption in proximal convoluted tubule in response to systemic application of U37883A.These findings suggest that the diuretic and natriuretic effect upstream to the distal tubule in response to systemic application of U37883A involves actions on water-permeable segments such as the proximal convoluted tubule.
机译:U37883A(ATP敏感性钾(KATP)通道的阻滞剂)的系统应用,可引起利尿和利尿作用,而不会显着改变尿中钾的排泄。慕尼黑-维斯塔-弗伦特大鼠在全身应用U37883A(1、5或15μmg·kg-1静脉注射)期间,观察到的对E37883A的真尿利尿和利尿作用在15μmg·kg-1的情况下伴随早期远端肾小管流量增加速率(VED)从10–18 nl min-1,反映到该部位的流体部分重吸收(FR流体)减少了13%。后者提出了对透水段的作用,例如近端小管,这可以完全解释观察到的Na +直至早期远端小管(FR-Na +)的分数重吸收减少8%,以及早期远端小管Na +的增加。浓度([Na +] ED)在35–51 mM,而[K +] ED则保持不变。相比之下,速尿(3 mg kg-1 iv)在不透水的粗大上升肢体中起作用,引起利尿,利尿和卡利尿病与FR-Na +下降10%而FR流体没有变化,[Na +] ED从42–117 mM升高,[K +] ED从1.2–5.7 mM升高而VED不变直接晚期近端肾小管积液证实对U37883A全身应用有明显抑制作用,可抑制近端旋回小管中的液体重吸收。这些发现表明,响应U37883A全身应用,远端小管上游的利尿和利钠作用涉及对水烫发可行的节段,例如近端的曲管。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号